Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
88.00
+1.14 (1.31%)
At close: Jun 4, 2026

EGX:PHAR Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
14,85113,0796,8295,4303,6214,155
Market Cap Growth
93.36%91.51%25.78%49.96%-12.86%-3.57%
Enterprise Value
23,92021,42614,5789,6305,3885,509
Last Close Price
88.0074.3641.4231.3622.7524.04
PE Ratio
10.439.076.236.605.638.52
Forward PE
-7.037.035.925.776.23
PS Ratio
1.541.390.901.040.921.22
PB Ratio
2.612.001.471.271.121.40
P/TBV Ratio
2.632.111.481.281.121.40
P/OCF Ratio
-11.96-58.71-10.83
PEG Ratio
-1.021.021.021.021.02
EV/Sales Ratio
2.472.271.921.841.361.62
EV/EBITDA Ratio
8.038.749.077.337.106.35
EV/EBIT Ratio
8.449.159.677.958.147.09
Debt / Equity Ratio
1.661.351.981.150.880.59
Debt / EBITDA Ratio
3.803.595.733.743.762.03
Net Debt / Equity Ratio
1.601.131.701.000.730.49
Net Debt / EBITDA Ratio
3.663.014.933.233.131.67
Net Debt / FCF Ratio
-5.80-28.25-1.92-1.93-2.77-27.25
Asset Turnover
0.550.560.600.630.660.66
Inventory Turnover
1.371.421.461.361.211.08
Quick Ratio
0.580.390.360.650.540.67
Current Ratio
1.061.161.121.941.722.13
Return on Equity (ROE)
28.31%26.06%24.60%21.95%20.71%16.78%
Return on Assets (ROA)
8.38%8.70%7.43%9.04%6.89%9.46%
Return on Invested Capital (ROIC)
13.38%14.54%10.39%13.21%10.69%14.11%
Return on Capital Employed (ROCE)
23.50%22.30%18.50%16.90%16.10%21.70%
Earnings Yield
9.47%11.02%16.04%15.14%17.76%11.74%
FCF Yield
-10.53%-2.00%-60.34%-40.48%-23.75%-1.28%
Dividend Yield
1.70%-3.62%3.19%4.40%6.24%
Payout Ratio
38.96%42.41%39.61%37.67%61.14%78.64%
Buyback Yield / Dilution
-12.11%-8.91%--50.00%--1.64%
Total Shareholder Return
-10.39%-8.91%3.62%-46.81%4.40%4.60%